Danish hearing device groups William Demant and GN Hearing retain their composure after news from the rival Bose resulted in nosediving share prices. However, the companies monitor the situation very closely. Analyst calls the stock market's reaction "extremely exaggerated."
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.